Fig. 32From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseDocking pose of compounds C22 at the binding site of BuChE [49]Back to article page